Diabetes Care Devices - India | Statista Market Forecast

Revenue in the Diabetes Care Devices market market in India is projected to reach US$921.30m in 2024.
Revenue is expected to demonstrate an annual growth rate (CAGR 2024-2029) of 13.59%, leading to a market volume of US$1.74bn by 2029.
In a global context, the majority of revenue will be generated the United States, with a forecasted amount of US$11.71bn in 2024.
In India, the Diabetes Care Devices market is increasingly embracing digital health innovations, enhancing patient engagement and self-management of diabetes.

Definition:
The Diabetes Care Devices market, a medical technology market, includes medical devices used in the management and treatment of diabetes. These devices range from blood glucose meters and continuous glucose monitoring systems to insulin pumps, insulin pens, and other related accessories. It is important to note that the market does not include pharmaceutical products used in the treatment of diabetes, such as insulin and oral hypoglycemic agents.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Key players in the market include Medtronic, Abbott Laboratories, and Roche Diagnostics. Further information on the key players can be found in the Market Shares boxes.

Blood glucose monitoring devices
Insulin delivery devices

Diabetes drugs
Diabetes supplements

The Diabetes Care Devices Market in India is witnessing considerable growth, fueled by factors such as the increasing prevalence of diabetes, advancements in technology, and heightened awareness about diabetes management among patients and healthcare providers.

Customer preferences: In India, there is a noticeable shift towards personalized diabetes management solutions, with consumers increasingly favoring smart glucose monitoring devices that sync with mobile applications. This trend is influenced by a younger demographic that values technology integration in healthcare. Moreover, cultural factors such as family involvement in health decisions are prompting demand for devices that facilitate collective care. As urban lifestyles become more prevalent, there is a growing preference for user-friendly, portable devices that cater to on-the-go monitoring and management of diabetes.

Trends in the market: In India, the Diabetes Care Devices Market is experiencing a surge in demand for innovative glucose monitoring solutions that integrate with mobile technology, reflecting a broader trend toward personalized healthcare. This shift is driven by a tech-savvy younger population that prioritizes real-time data and convenience in diabetes management. Additionally, the emphasis on family involvement in health decisions is fostering the popularity of collaborative care devices. As urban lifestyles evolve, stakeholders must adapt by developing user-friendly, portable devices that support proactive diabetes management, ensuring they meet the needs of an increasingly mobile consumer base.

Local special circumstances: In India, the Diabetes Care Devices Market is influenced by a diverse population and varying access to healthcare resources. The prevalence of diabetes, particularly in urban areas, is prompting a shift toward affordable and accessible monitoring solutions tailored to local needs. Cultural factors, such as family-centric health decisions, drive demand for devices that facilitate shared management among family members. Moreover, regulatory initiatives aimed at enhancing healthcare access and safety standards are fostering innovation, encouraging local manufacturers to develop cost-effective, user-friendly devices that align with the country’s unique healthcare landscape.

Underlying macroeconomic factors: The Diabetes Care Devices Market in India is significantly shaped by macroeconomic factors such as rising disposable incomes, urbanization, and an increasing prevalence of diabetes linked to lifestyle changes. National economic health, characterized by GDP growth and healthcare spending, enhances consumer access to advanced medical devices. Fiscal policies promoting healthcare investment and innovation further stimulate market growth. Additionally, global trends like technological innovation and partnerships with international manufacturers are driving the development of cost-effective diabetes care solutions, making them more accessible to the diverse Indian population.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.